APTOCROM Inc. (KOSDAQ:109960)
South Korea flag South Korea · Delayed Price · Currency is KRW
164.00
-2.00 (-1.20%)
At close: Mar 25, 2026

APTOCROM Company Description

APTOCROM Inc. distributes pharmaceutical products in South Korea.

It operates through pharmaceutical business, leasing business, and insulation divisions. The company is involved in design, manufacturing, and construction of insulation; design, manufacturing and installation of removable insulation materials; design, production, and construction of nuclear power plant special insulation; and foam glass insulation material molding and construction.

It also offers medicines for the digestive system, including ijilong solution, gabespan soft capsule, etc.; and medicines for external skin, including lavender cream, barclax ointment, etc. In addition, the company is involved in real estate leasing, including office, laboratory, etc.; leasing business of pharmaceutical products; and equipment leasing.

The company was formerly known as AP Healthcare Inc. and changed its name to APTOCROM Inc. in September 2025.

APTOCROM Inc. was founded in 1998 and is headquartered in Seongnam-si, South Korea.

APTOCROM Inc.
CountrySouth Korea
Founded1998
IndustryDrugs, Drug Proprietaries, and Druggists' Sundries
Employees14
CEOHui Chang

Contact Details

Address:
545, B1, Duncheon-daero
Seongnam-si
South Korea
Phone82 31 8022 0595
Websiteaprogen-hng.com

Stock Details

Ticker Symbol109960
ExchangeKOSDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyKRW
SIC Code5122

Key Executives

NamePosition
Hui ChangChief Executive Officer